Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for LEE011

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCBRE15147

    01/20/2017

    A randoMized phAse II trIal of fulvestraNt wiTh or without Ribociclib After progression on AntI-estrogeN therapy plus cyclin-dependent kinase 4/6 inhibition in patients with unresectable or metastatic hormone receptor positive, HER2 negative breast cancer (MAINTAIN Trial)


    Print this page for your doctor